Kevin Tang

Kevin Tang appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 15 filings, for trades running from 12 September 2024 to 2 June 2026.

On the market, this insider has only ever bought: 8 purchases, €7.7M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 8 purchases and no sales on the market.

A typical purchase (the median) is worth €977k. Scaled by market value, the purchases weigh a median 0.046% of market cap (sample: 8 purchases). Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 3 June 2026, reports a transaction of €5,122 in Aurinia Pharmaceuticals Inc. The latest purchase dates back some time: it was published 136 days ago, on 3 June 2026. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.